Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  London Stock Exchange  >  Quantum Pharma PLC    0N0V   GB00BRTL8Q42

QUANTUM PHARMA PLC (0N0V)
Mes dernières consult.
Most popular
  Report  
 SummaryQuotesNewsCalendarCompanyFinancialsRevisions 
Financials ( GBP)
More Financials
Company
Quantum Pharma Plc engages in the manufacture and supply of niche medicines and provision of services to the health care sector.It operates through the following segments: Specials, Niche Pharmaceuticals and Medication Adherence.The Specials segments manufactures, sources, and supplies specials to... 
Sector
Pharmaceuticals
Calendar
05/23Earnings Release
More about the company
Latest news on QUANTUM PHARMA PLC
2017Clinigen group plc. - board changes
AQ
2017QUANTUM PHARMA : Temporary suspension of trading on aim
PU
2017CLINIGEN : agrees to buy rival firm Quantum
AQ
2017CLINIGEN : boost unlicensed drugs business with Quantum takeover
RE
2017QUANTUM PHARMA : OML - Form 8.3 - Quantum Pharma Plc
PU
2017QUANTUM PHARMA : Form 8.5 (EPT/RI) - Quantum
PU
2017QUANTUM PHARMA : Unaudited results for the half year ended 31 July 2017 ('the pe..
PU
2017RATHBONES : Form 8.3 - [Quantum Pharma PLC]
PU
2017FORM 8.3 - AXA INVESTMENT MANAGERS : Quantum Pharma Plc
PU
2017CLINIGEN : Possible Offer for Quantum Pharma plc
AQ
More news
Sector news : Pharmaceuticals - NEC
02/16S&P 500 caps off strongest week in five years
RE
02/16ASTRAZENECA : U.S. FDA approves AstraZeneca's immunotherapy for lung cancer
RE
02/16NOVARTIS : readies to auction U.S. generic pills business - sources
RE
02/16Backstory - Warren Buffett's Valentine's Day surprise for investors
RE
02/16WARREN BUFFETT : Warren Buffett's Valentine's Day surprise for investors
RE
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
2017Why It Can Pay To Accept The Discomfort Of Buying Stocks Hitting New Highs 
2017Quantum Pharma PLC 2017 Q2 - Results - Earnings Call Slides 
Income Statement Evolution
Managers
NameTitle
Christian Alexander Rigg Chief Executive Officer & Executive Director
Ian Roy Johnson Non-Executive Chairman
Gerard Thomas Murray Chief Financial Officer & Executive Director
Christopher Harwood Bernard Mills Independent Non-Executive Director
John Robert Brown Senior Independent Non-Executive Director
Sector and Competitors
1st jan.Capitalization (M$)
QUANTUM PHARMA PLC0.00%0
JOHNSON & JOHNSON-7.19%352 552
NOVARTIS-3.37%224 301
PFIZER-2.84%212 857
ROCHE HOLDING LTD.-9.37%210 327
MERCK AND COMPANY-0.50%149 572